Suppr超能文献

尖端扭转型室性心动过速。丙吡胺与奎尼丁共有的一种并发症。

Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine.

作者信息

Wald R W, Waxman M B, Colman J M

出版信息

J Electrocardiol. 1981 Jul;14(3):301-7. doi: 10.1016/s0022-0736(81)80013-1.

Abstract

Two cases of documented torsade de pointes ventricular tachycardia in association with the use of disopyramide are described. One patient had previously experienced an episode suggestive of quinidine induced ventricular tachycardia while the other developed ventricular tachycardia during quinidine treatment which was later exacerbated and sustained by the administration of disopyramide. Both patients exhibited a prolonged QTc or QUc interval at the time of the arrhythmia. These cases suggest that a propensity of ventricular arrhythmias induced by quinidine may identify individuals who are likely to develop similar arrhythmias disopyramide treatment as well.

摘要

本文描述了两例记录在案的与使用丙吡胺相关的尖端扭转型室性心动过速病例。一名患者曾经历过一次提示为奎尼丁诱发的室性心动过速发作,而另一名患者在奎尼丁治疗期间发生室性心动过速,随后因使用丙吡胺而病情加重并持续发作。两名患者在心律失常发作时均表现出QTc或QUc间期延长。这些病例表明,奎尼丁诱发室性心律失常的倾向可能也能识别出那些在接受丙吡胺治疗时可能发生类似心律失常的个体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验